These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 36227676)

  • 21. Knockdown of TRIM44 Inhibits the Proliferation and Invasion in Prostate Cancer Cells.
    Tan Y; Yao H; Hu J; Liu L
    Oncol Res; 2017 Sep; 25(8):1253-1259. PubMed ID: 28160462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long non-coding RNA KCNQ1OT1 promotes proliferation, migration and invasion via targeting miR-134 in retinoblastoma.
    Wang L; Yi S; Wang R; Wang J
    J Gene Med; 2021 Jun; 23(6):e3336. PubMed ID: 33818859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Down-regulation of long non-coding RNA DUXAP8 suppresses proliferation, metastasis and EMT by modulating miR-498 through TRIM44-mediated AKT/mTOR pathway in non-small-cell lung cancer.
    Ji X; Tao R; Sun LY; Xu XL; Ling W
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3152-3165. PubMed ID: 32271433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trim44 facilitates the migration and invasion of human lung cancer cells via the NF-κB signaling pathway.
    Luo Q; Lin H; Ye X; Huang J; Lu S; Xu L
    Int J Clin Oncol; 2015 Jun; 20(3):508-17. PubMed ID: 25345539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TRIM44 promotes proliferation and metastasis in non‑small cell lung cancer via mTOR signaling pathway.
    Xing Y; Meng Q; Chen X; Zhao Y; Liu W; Hu J; Xue F; Wang X; Cai L
    Oncotarget; 2016 May; 7(21):30479-91. PubMed ID: 27058415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ELFN1-AS1 accelerates the proliferation and migration of colorectal cancer via regulation of miR-4644/TRIM44 axis.
    Lei R; Feng L; Hong D
    Cancer Biomark; 2020; 27(4):433-443. PubMed ID: 31929141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High TRIM44 expression in endometrial carcinoma is associated with a poorer patient outcome.
    Li P; Yin H; Meng F; Liu S; Liu H; Ma R
    Pathol Res Pract; 2018 May; 214(5):727-731. PubMed ID: 29526558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knockdown of HIF1A-AS2 suppresses TRIM44 to protect cardiomyocytes against hypoxia-induced injury.
    Luo F; Wu Y; Zhu L; Zhang J; Liu Y; Jia W
    Cell Biol Int; 2020 Jul; 44(7):1523-1534. PubMed ID: 32222118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TRIM44 is indispensable for glioma cell proliferation and cell cycle progression through AKT/p21/p27 signaling pathway.
    Zhou X; Yang Y; Ma P; Wang N; Yang D; Tu Q; Sun B; Xiang T; Zhao X; Hou Z; Fang X
    J Neurooncol; 2019 Nov; 145(2):211-222. PubMed ID: 31605296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TRIM44 Promotes Rabies Virus Replication by Autophagy-Dependent Mechanism.
    He H; Cai T; Chen Q; Chen Z; Zhang B; Chen C; Wang Y; Liu Y; Wang Y; Luo Y; Huang S; Luo J; Guo X
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor necrosis factor superfamily member 13 is a novel biomarker for diagnosis and prognosis and promotes cancer cell proliferation in laryngeal squamous cell carcinoma.
    Wang R; Guo Y; Ma H; Feng L; Wang Q; Chen X; Lian M; Wang H; Fang J
    Tumour Biol; 2016 Feb; 37(2):2635-45. PubMed ID: 26395262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-cancer effect of miR-139-3p on laryngeal squamous cell carcinoma by targeting rab5a: In vitro and in vivo studies.
    Ma Y; Gong Z; Wang H; Liang Y; Huang X; Yu G
    Pathol Res Pract; 2020 Nov; 216(11):153194. PubMed ID: 32916448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitor of Growth 4 (ING4) Plays a Tumor-repressing Role in Oral Squamous Cell Carcinoma via Nuclear Factor Kappa-B (NF-kB)/DNA Methyltransferase 1 (DNMT1) Axis-mediated Regulation of Aldehyde Dehydrogenase 1A2 (ALDH1A2).
    Cui Z; Sun S; Li J; Li J; Sha T; He J; Zuo L
    Curr Cancer Drug Targets; 2022; 22(9):771-783. PubMed ID: 35388759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The expression of SOCS1 and TLR4-NFkappaB pathway molecules in neoplastic cells as potential biomarker for the aggressive tumor phenotype in laryngeal carcinoma.
    Starska K; Forma E; Lewy-Trenda I; Stasikowska O; Bryś M; Krajewska WM; Łukomski M
    Folia Histochem Cytobiol; 2009 Jan; 47(3):401-10. PubMed ID: 20164024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-34a-5p directly targeting TRIM44 affects the biological behavior of ovarian cancer cells.
    Li HL; Duan YA; Zhao N
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1250-1260. PubMed ID: 33629295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-192-5p suppresses the progression of lung cancer bone metastasis by targeting TRIM44.
    Zou P; Zhu M; Lian C; Wang J; Chen Z; Zhang X; Yang Y; Chen X; Cui X; Liu J; Wang H; Wen Q; Yi J
    Sci Rep; 2019 Dec; 9(1):19619. PubMed ID: 31873114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High expression of TRIM44 is associated with enhanced cell proliferation, migration, invasion, and resistance to doxorubicin in hepatocellular carcinoma.
    Zhu X; Wu Y; Miao X; Li C; Yin H; Yang S; Lu X; Liu Y; Chen Y; Shen R; Chen X; He S
    Tumour Biol; 2016 Nov; 37(11):14615-14628. PubMed ID: 27619678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TRIM44, a Novel Prognostic Marker, Supports the Survival of Proteasome-Resistant Multiple Myeloma Cells.
    Vu T; Wang Y; Fowler A; Simieou A; McCarty N
    Cells; 2024 Aug; 13(17):. PubMed ID: 39273003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of tripartite motif-containing 44 and its prognostic and clinicopathological value in human malignancies:a meta-analysis.
    Xiao G; Yang Q; Bao Z; Mao H; Zhang Y; Lin S
    BMC Cancer; 2020 Jun; 20(1):525. PubMed ID: 32503466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack.
    Szczepanski MJ; Czystowska M; Szajnik M; Harasymczuk M; Boyiadzis M; Kruk-Zagajewska A; Szyfter W; Zeromski J; Whiteside TL
    Cancer Res; 2009 Apr; 69(7):3105-13. PubMed ID: 19318560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.